Enterprise ELNs as a foundation for preclinical drug development

To have real business impact within preclinical drug development, Enterprise ELNs (Electronic Laboratory Notebooks) must provide a secure, scalable and searchable data management backbone across all disciplines focused on development of both small and large molecules, in compliant and non-compliant environments. Through more effective capture and reuse of data and knowledge, we discuss how Enterprise ELNs improve inter- and intra-departmental collaboration, and support quality initiatives such as ‘Quality by Design’.